ZOE
PrivateLast Round
Series B
Apr 30, 2025
Est. Valuation
$332.5M
Total Funding Raised
$138.81M
Company Overview
ZOE is a nutrition science company that provides personalized dietary plans and health insights through at-home medical testing services analyzing gut microbiome, blood fat, and blood sugar responses.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, D2C Brands, Subscription Commerce, Sports & Fitness
Business Model
B2C
Customer Profile
Subscription SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ZOE Comparables
Compare ZOE with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Viome Life Sciences | 84% | |
| Levels | 83% | |
| Signos | 79% |
ZOE Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 30, 2025 | ||||
| Series B Extension | Jul 29, 2024 | ||||
| Series B Extension | Mar 15, 2023 | ||||
| Series B Extension | Dec 1, 2022 | ||||
| Series B | May 4, 2021 | ||||
Series A | Jun 1, 2019 |
ZOE Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Coefficient Capital | Series B Extension |
| Accomplice | Series A, Series B, Series B Extension |
| Falcon Wealth Planning | Series B |
| Daphni | Series A, Series B, Series B Extension |
| L Catterton | Series B Extension |
| Sageview Capital | Series B |
| THVC | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
Monthly visitors grew 49% MoM, reaching 18.8K.
- Jan 8, 2026
Monthly visitors grew 482% MoM, reaching 12.6K.
ZOE Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ZOE's valuation, stock price, and market status.
Is ZOE a public or private company?
ZOE is a private company.
What is the current stock price of ZOE?
ZOE is a private company with no public stock price. No recent secondary market data is available.
How much is ZOE worth (valuation)?
ZOE's valuation is estimated at $250.0M based on funding round data.
Can I buy ZOE stock?
ZOE shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ZOE's last funding round?
ZOE's most recent funding round was Series B on July 29, 2024.
Who are the main investors in ZOE?
Key investors in ZOE include Coefficient Capital, Accomplice, Sageview Capital, Ahren Innovation Capital.
Will ZOE IPO soon?
No public IPO plans have been announced for ZOE.
How can I track ZOE secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ZOE's secondary market activity and sign up for updates.